MENU
+Compare
RNTX
Stock ticker: NASDAQ
AS OF
Oct 15, 12:37 PM (EDT)
Price
$1.33
Change
-$0.01 (-0.75%)
Capitalization
31.96M

RNTX Rein Therapeutics Inc Forecast, Technical & Fundamental Analysis

Rein Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

RNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for RNTX with price predictions
Oct 14, 2025

Momentum Indicator for RNTX turns positive, indicating new upward trend

RNTX saw its Momentum Indicator move above the 0 level on October 06, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 94 similar instances where the indicator turned positive. In of the 94 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 65 cases where RNTX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for RNTX just turned positive on September 25, 2025. Looking at past instances where RNTX's MACD turned positive, the stock continued to rise in of 37 cases over the following month. The odds of a continued upward trend are .

RNTX moved above its 50-day moving average on October 07, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for RNTX crossed bullishly above the 50-day moving average on October 07, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RNTX advanced for three days, in of 211 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 134 cases where RNTX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for RNTX moved out of overbought territory on October 08, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RNTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

RNTX broke above its upper Bollinger Band on October 07, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.627) is normal, around the industry mean (24.376). P/E Ratio (0.000) is within average values for comparable stocks, (54.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.175). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (341.418).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. RNTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RNTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
RNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UHG4.200.04
+1.08%
United Homes Group
AKTX0.94N/A
+0.11%
Akari Therapeutics plc
PTCT66.090.03
+0.05%
PTC Therapeutics
MRC13.22-0.04
-0.30%
MRC Global
WMB62.36-0.32
-0.51%
Williams Companies

RNTX and Stocks

Correlation & Price change

A.I.dvisor tells us that RNTX and ATOS have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RNTX and ATOS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNTX
1D Price
Change %
RNTX100%
+0.76%
ATOS - RNTX
26%
Poorly correlated
-2.03%
AVXL - RNTX
26%
Poorly correlated
+2.03%
IKT - RNTX
25%
Poorly correlated
-1.10%
GNLX - RNTX
24%
Poorly correlated
+0.57%
NNVC - RNTX
24%
Poorly correlated
-0.74%
More